Who are IGC Pharma, Inc.'s main suppliers?

IGC Pharma, Inc. (IGC) key suppliers include: O-BANK-CO-LTD, ONE-DECK-CAPITAL-INC, VFG, Axsome Therapeutics, Inc., Axsome Therapeutics, Inc. and 2 more. View the full supplier network at chainsifter.com/chain/IGC.

Who are IGC Pharma, Inc.'s major customers?

IGC Pharma, Inc. (IGC) key customers include: FMW-MEDIA-WORKS-LLC, Axsome Therapeutics, Inc., Axsome Therapeutics, Inc., ORANY, ORANY. View the full customer network at chainsifter.com/chain/IGC.

What sector is IGC Pharma, Inc. in?

IGC Pharma, Inc. (IGC) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

IGC Supply Chain: IGC Pharma, Inc. Supplier List & 15 Relationships

7Suppliers

5Customers

3Debt Items

20Related Chains

IGC Pharma, Inc. Suppliers

Ticker	Name	Confidence	Evidence
O-BANK-CO-LTD	O-BANK-CO-LTD	92%	IGC Pharma, Inc. entered into an amendment to extend its existing Master Loan and Security Agreement together with the General Banking Facility Letter (collectively, the "Loan Agreement") with O-Bank…
ONE-DECK-CAPITAL-INC	ONE-DECK-CAPITAL-INC	90%	The Company entered into a loan agreement with One Deck Capital, Inc. ("One Deck"), pursuant to which the Company received approximately $219,000 in financing (the "One Deck Loan")
VFG	VFG	90%	VFG is prohibited from converting any amount of the Note that would result in VFG and its affiliates beneficially owning more than 4.99% of the outstanding shares of Common Stock
AXSM	Axsome Therapeutics, Inc.	72%	ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and customer experiences. We hope to leverage our …
AXSM	Axsome Therapeutics, Inc.	72%	Reciprocal relationship from AXSM graph: Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative produc…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative produ…
ORANY	ORANY	72%	ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and customer experiences. We hope to leverage our …

IGC Pharma, Inc. Customers

Ticker	Name	Confidence	Evidence
FMW-MEDIA-WORKS-LLC	FMW-MEDIA-WORKS-LLC	90%	The Company issued a press release announcing a strategic national media partnership with FMW Media Works LLC
AXSM	Axsome Therapeutics, Inc.	72%	ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and customer experiences. We hope to leverage our …
AXSM	Axsome Therapeutics, Inc.	72%	Reciprocal relationship from AXSM graph: Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative produc…
ORANY	ORANY	72%	ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative products that drive positive patient and customer experiences. We hope to leverage our …
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from IGC graph: ing growth of the Life Sciences segment. These investments will fuel the development and delivery of innovative produ…

IGC Pharma, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
IGC-DEBT-10198	Xbrl Convertible	90%	xbrl convertible detail from xbrl 2019-03-31.
IGC-DEBT	Debt stack $146,000	90%	Market cache reports total debt of $146,000.
IGC-DEBT-10197	Warrants outstanding: 1167217	90%	xbrl warrant detail from xbrl 2021-03-31.

IGC Pharma, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for IGC Pharma, Inc..

IGC Pharma, Inc. Ownership

No ownership data on recordNo major institutional ownership relationships found in our database for IGC Pharma, Inc..

IGC Pharma, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
ORANY	ORANGE	100.00	1	['customer', 'supplier']
AXSM	Axsome Therapeutics, Inc.	100.00	1	['customer', 'supplier']
AMZE	Amaze Holdings, Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
D	Dominion Energy, Inc.	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
DWTX	Dogwood Therapeutics, Inc.	50.00	2
CANF	Can-Fite BioPharma Ltd.	50.00	2
DFTX	Definium Therapeutics, Inc.	50.00	2
CHUC	Charlie's Holdings, Inc.	50.00	2
CLNE	Clean Energy Fuels Corp.	50.00	2
FENC	Fennec Pharmaceuticals Inc.	50.00	2
EQR	Equity Residential	50.00	2
CNOB	ConnectOne Bancorp, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
ESS	Essex Property Trust, Inc.	50.00	2
ED	Consolidated Edison, Inc.	50.00	2
SCNX	Scienture Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2

IGC Pharma, Inc. Supply Chain